World J Nephrol Urol

World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access

Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc

Journal website http://www.wjnu.org

Review

Volume 1, Number 1, February 2012, pages 1-7

Use of Bisphosphonates in Chronic Kidney Disease

Tables

**Table 1.** Stages of Chronic Kidney Disease
Stage	Description	GFR* mL/min/1.73m²
*GFR, glomerular filtration rate.
1	Slight kidney damage with normal or increased filtration	More than 90
2	Mild decrease in kidney function	60 - 89
3	Moderate decrease in kidney function	30 - 59
4	Severe decrease in kidney function	15 - 29
5	Kidney failure	Less than 15 (or dialysis)

**Table 2.** Bisphosphonate Prescribing Advice for Persons With Reduced Renal Function
Bisphosphonate	Recommendation
GFR: glomerular filtration rate; CrCl: creatinine clearance; min: minute.
Alendronat	GFR < 35 ml/min
Pamidronat	CrCl < 30 ml/min
Risedronat	CrCl < 30 ml/min
Ibandronik asid	CrCl < 30 ml/min
Zoledronik asid	CrCl < 40 ml/min
Etidronat	Mild and moderate renal disease